High-dose chemotherapy followed by reinfusion of a high number of CD34+ progenitor cells is frequently associated with development of fever in the postengraftment period

A. P. Jillella, S. W. Helman, J. Larison, M. S. Litaker, L. O. Cook

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'High-dose chemotherapy followed by reinfusion of a high number of CD34+ progenitor cells is frequently associated with development of fever in the postengraftment period'. Together they form a unique fingerprint.

Medicine & Life Sciences